Dr Reddy’s settles patent issue with Novartis (Business Standard India)
Dr Reddy’s settles patent issue with Novartis (Business Standard India)
Dr Reddy’s Laboratories has settled a patent dispute in the US with the Switzerland-based drug maker Novartis Pharma over Exelon (rivastigmine tartrate), used in the treatment of a type of dementia of the Alzheimer’s type.